EWS & EVENTS
Agonist Redirected Checkpoint Platform (ARC); Engineering Bi-Functional Fusion Proteins (PD1-Fc-OX40L), for Cancer Immunotherapy

SITC 2018

2018_SITC_PD1OX40L
MIGHT ALSO LIKE
YOU MIGHT ALSO LIKE
Agonist Redirected Checkpoint Platform (ARC); Engineering Bi-Functional Fusion Proteins (TIM3-Fc-OX40L and TIM3-Fc-CD40L), for Cancer Immunotherapy

SITC 2018

Read more
Taylor Schreiber to present at CD47/SIRPα Summit

“THE CD47/SIRPα  2019 SUMMIT IS A VALUABLE OPPORTUNITY TO SHARE OUR LEARNINGS AND EXPLORE IMPORTANT QUESTIONS ABOUT TARGETING THE MYELOID CHECKPOINT…

Read more